New Approaches for Cancer Treatment: Antitumor Drugs Based on Gene-Targeted Nucleic Acids

por Patutina, O.A., Mironova, N.L., Vlassov, V.V., Zenkova, M.A.
Publicado 2009

Molecular and Cellular Mechanisms of Antitumor Immune Response Activation by Dendritic Cells

por Markov, O. V., Mironova, N. L., Vlasov, V. V., Zenkova, M. A.
Publicado 2016

Antitumor Vaccines Based on Dendritic Cells: From Experiments using Animal Tumor Models to Clinical Trials

por Markov, O. V., Mironova, N. L., Vlassov, V. V., Zenkova, M. A.
Publicado 2017

RNase T1 mimicking artificial ribonuclease

por Mironova, N. L., Pyshnyi, D. V., Shtadler, D. V., Fedorova, A. A., Vlassov, V. V., Zenkova, M. A.
Publicado 2007

Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H

por Patutina, O. A., Bazhenov, M. A., Miroshnichenko, S. K., Mironova, N. L., Pyshnyi, D. V., Vlassov, V. V., Zenkova, M. A.
Publicado 2018

Tumoricidal Activity of RNase A and DNase I

por Patutina, O.A., Mironova, N.L., Ryabchikova, E.I., Popova, N.A., Nikolin, V.P., Kaledin, V.I., Vlassov, V.V., Zenkova, M.A.
Publicado 2010